Although not perfect, PCA3 outperformed PSA and free PSA in predicting cancer detection on repeated biopsy when previous biopsy was negative.44 However, most papers included in the review had small sample sizes and used different criteria for biopsy referral and cut-off point to define an abnormal test. Here, KLK3 is linked to cancer.